Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.4946
-0.05-9.23%
At close: -
$0.4971
0.002500.51%
After Hours: May 30, 7:14 PM EDT
Comments
Loading...
Verrica Pharmaceuticals Stock Price, Quotes and Forecasts
VRCANASDAQ
Verrica Pharmaceuticals (VRCA) Forecast
NewsEarningsVerrica Pharmaceuticals (VRCA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Verrica Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:VRCA | Benzinga
Explore Verrica Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VRCA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verrica Pharmaceuticals (VRCA) stock?
You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.
Who are Verrica Pharmaceuticals (VRCA) competitors?
Other companies in Verrica Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), Universe Pharmaceuticals (NASDAQ:UPC) and Nutriband (NASDAQ:NTRB).
What is the forecast, or price target, for Verrica Pharmaceuticals (VRCA) stock?
Verrica Pharmaceuticals has a consensus price target of $7.50.
What is the current price for Verrica Pharmaceuticals (VRCA)?
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $0.4971 last updated May 30, 2025 at 7:14 PM EDT.
Does Verrica Pharmaceuticals (VRCA) pay a dividend?
There are no upcoming dividends for Verrica Pharmaceuticals.
When is Verrica Pharmaceuticals (NASDAQ:VRCA) reporting earnings?
Verrica Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
Is Verrica Pharmaceuticals (VRCA) going to split?
There is no upcoming split for Verrica Pharmaceuticals.
What sector and industry does Verrica Pharmaceuticals (VRCA) operate in?
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
